Comparative Evaluation of BGR-34 and Sitagliptin in Diabetic Subjects - Open Labelled Randomised Parallel Clinical Study

Pubblicato online: 02 feb 2022

Pagine: 325 - 332

Ricevuto: 05 ott 2020

Accettato: 06 mar 2021

DOI: https://doi.org/10.2478/sjecr-2021-0057

Parole chiave

diabetes mellitus, blood glucose regulator-34, DPP-4 inhibitors, hyperglycemia, sitagliptin

© 2021 Ravinder Singh et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.